Elihu H. Estey, M.D.Professor of MedicineDivision of HematologyUniversity of Washington School of MedicineMember, Fred Hutchinson Cancer Research Center Attending Physician, Seattle Cancer Care AllianceSeattle, WA   USAFrederick R. Appelbaum, MD Professor of MedicineHead, Division of OncologyDirector, Clinical Research Division,Fred Hutchinson Cancer Research CenterExecutive Director, Seattle Cancer Care AllianceUniversity of Washington School of MedicineSeattle, WA   USA

From the reviews: "The book represents an excellent and actual source of knowledge about leukemias and blood stem cell transplantation and should not be missing in any transplantation department worldwide. It can be recommended also for residents, fellows in training as well as for specialist looking for concentrated information in this field of interest." (M. Hrubisko, Neoplasma, Issue 1, 2013)

• 1. Acute Myeloid Leukemia (AML).- 2. The Treatment of Adult Acute Lymphoblastic Leukemia (ALL):  Risk Stratification and Strategies.- 3. Chronic Lymphocytic Leukemia (CLL).- 4. Chronic Myelogenous Leukemia (CML).- 5. Myelodysplastic Syndromes (MDS).- 6. Myeloablative transplant (HCT).- 7. Reduced-intensity and Non-Myeloablative Conditioning Followed by Hematopoietic Cell Transplantation.- 8. Alternative Donor Hematopoietic Stem Cell Transplantation – A Role for Umbilical Cord Blood Transplantation for Hematologic Malignancies.- 9. The Detection and Significance of Minimal Residual Disease.- 10. Late Effects after Treatment for Leukemia.- 11. Transfusion Support of the Patient with Hematologic Malignancy.- 12. Infections in Leukemia and Hematopoietic Stem Cell Transplantation.

Elihu H. Estey, M.D.Professor of MedicineDivision of HematologyUniversity of Washington School of MedicineMember, Fred Hutchinson Cancer Research Center Attending Physician, Seattle Cancer Care AllianceSeattle, WA   USAFrederick R. Appelbaum, MD Professor of MedicineHead, Division of OncologyDirector, Clinical Research Division,Fred Hutchinson Cancer Research CenterExecutive Director, Seattle Cancer Care AllianceUniversity of Washington School of MedicineSeattle, WA   USA

From the reviews: "The book represents an excellent and actual source of knowledge about leukemias and blood stem cell transplantation and should not be missing in any transplantation department worldwide. It can be recommended also for residents, fellows in training as well as for specialist looking for concentrated information in this field of interest." (M. Hrubisko, Neoplasma, Issue 1, 2013)

• 1. Acute Myeloid Leukemia (AML).- 2. The Treatment of Adult Acute Lymphoblastic Leukemia (ALL):  Risk Stratification and Strategies.- 3. Chronic Lymphocytic Leukemia (CLL).- 4. Chronic Myelogenous Leukemia (CML).- 5. Myelodysplastic Syndromes (MDS).- 6. Myeloablative transplant (HCT).- 7. Reduced-intensity and Non-Myeloablative Conditioning Followed by Hematopoietic Cell Transplantation.- 8. Alternative Donor Hematopoietic Stem Cell Transplantation – A Role for Umbilical Cord Blood Transplantation for Hematologic Malignancies.- 9. The Detection and Significance of Minimal Residual Disease.- 10. Late Effects after Treatment for Leukemia.- 11. Transfusion Support of the Patient with Hematologic Malignancy.- 12. Infections in Leukemia and Hematopoietic Stem Cell Transplantation.

Elihu H. Estey, M.D.Professor of MedicineDivision of HematologyUniversity of Washington School of MedicineMember, Fred Hutchinson Cancer Research Center Attending Physician, Seattle Cancer Care AllianceSeattle, WA   USAFrederick R. Appelbaum, MD Professor of MedicineHead, Division of OncologyDirector, Clinical Research Division,Fred Hutchinson Cancer Research CenterExecutive Director, Seattle Cancer Care AllianceUniversity of Washington School of MedicineSeattle, WA   USA

From the reviews: "The book represents an excellent and actual source of knowledge about leukemias and blood stem cell transplantation and should not be missing in any transplantation department worldwide. It can be recommended also for residents, fellows in training as well as for specialist looking for concentrated information in this field of interest." (M. Hrubisko, Neoplasma, Issue 1, 2013)

• 1. Acute Myeloid Leukemia (AML).- 2. The Treatment of Adult Acute Lymphoblastic Leukemia (ALL):  Risk Stratification and Strategies.- 3. Chronic Lymphocytic Leukemia (CLL).- 4. Chronic Myelogenous Leukemia (CML).- 5. Myelodysplastic Syndromes (MDS).- 6. Myeloablative transplant (HCT).- 7. Reduced-intensity and Non-Myeloablative Conditioning Followed by Hematopoietic Cell Transplantation.- 8. Alternative Donor Hematopoietic Stem Cell Transplantation – A Role for Umbilical Cord Blood Transplantation for Hematologic Malignancies.- 9. The Detection and Significance of Minimal Residual Disease.- 10. Late Effects after Treatment for Leukemia.- 11. Transfusion Support of the Patient with Hematologic Malignancy.- 12. Infections in Leukemia and Hematopoietic Stem Cell Transplantation.